Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robert Nanduri"'
Autor:
Manoranjan Panda, Anandkumar Raichurkar, Neela Dinesh, Vinayak Hosagrahara, Naveen Kumar, K.R. Prabhakar, Suresh Rudrapatna, Gayathri Balakrishnan, Amit K. Gupta, Vasan K. Sambandamurthy, Karthikeyan Kandaswamy, Stefan Kavanagh, Ramanatha Saralaya, Lalit kumar Jena, Shridhar Narayanan, Suresh Solapure, Robert Nanduri, V. Balasubramanian, Meenakshi Mallya, Ashwini Narayan, Sowmya Bharath, Vijender Panduga, Vikas Shinde, Jitendar Reddy, Khisi Mdluili, Christopher B. Cooper, Parvinder Kaur, Shahul Hameed P, Sreevalli Sharma, Supreeth Guptha, Kakoli Mukherjee, Sudha Ravishankar, Radha Shandil, Pravin Iyer, Shankar D. Markad, Vasanthi Ramachandran, Takahiro Yano, Jyothi Bhat, Harvey Rubin, Subramanyam J. Tantry
Publikováno v:
MedChemComm. 7:1022-1032
The success of bedaquiline as an anti-tubercular agent for the treatment of multidrug-resistant tuberculosis has validated the ATP synthesis pathway and in particular ATP synthase as an attractive target. However, limitations associated with its use
Autor:
Swaminathan Rajagopalan, Jitendar Reddy, Vijender Panduga, K.R. Prabhakar, Naveen Kumar, Anand Anandkumar, Ragini Singh, Vasanthi Ramachandran, Swati Khandelwal, Santanu Datta, Narasimha Rao, Shridhar Narayanan, Suresh Solapure, Malancha Karmarkar, Radha Shandil, V. Balasubramanian, Ramanatha Saralaya, Robert Nanduri, Sreevalli Sharma
Publikováno v:
Antimicrobial Agents and Chemotherapy
There are currently 18 drug classes for the treatment of tuberculosis, including those in the development pipeline. An in silico simulation enabled combing the innumerably large search space to derive multidrug combinations. Through the use of ordina
Autor:
K.R. Prabhakar, Iñigo Angulo-Barturen, Sandra Duffy, Ramachandran Sreekanth A, Shridhar Narayanan, Francisco-Javier Gamo, Laura M. Sanz, Santiago Ferrer, Anandkumar Raichurkar, María Belén Jiménez-Díaz, Vijender Panduga, Sreenivasaiah Menasinakai, Gajanan Shanbhag, Robert Nanduri, Marcus C. S. Lee, Nikhil Rautela, Sapna Morayya, Vinayak Hosagrahara, Disha Awasthy, Olivia Coburn-Flynn, María Santos Martínez, Sowmya Bharath, Jitendar Reddy, Vicky M. Avery, David Waterson, Abhishek Srivastava, Vasan K. Sambandamurthy, Ramanatha Saralaya, Vijayashree Achar, Pravin Iyer, Stefan Kavanagh, David A. Fidock, Shahul Hameed P
Publikováno v:
Journal of medicinal chemistry. 57(15)
From the phenotypic screening of the AstraZeneca corporate compound collection, N-aryl-2-aminobenzimidazoles have emerged as novel hits against the asexual blood stage of Plasmodium falciparum (Pf). Medicinal chemistry optimization of the potency aga
Autor:
Vijender Panduga, Robert Nanduri, Pravin Iyer, Manoranjan Panda, Lalit kumar Jena, Claire Sadler, Anisha Ambady, Sudha Ravishankar, Rudrapatna S. Suresh, M. R. Manjunatha, Shridhar Narayanan, K.R. Prabhakar, Khisi Mdluli, Sreevalli Sharma, James D. Whiteaker, Scott Butler, Pravin S. Shirude, Radha Shandil, Vaishali Humnabadkar, Monalisa Chatterji, Abhishek Srivastava, Ramanatha Saralaya, Jitendar Reddy, Robert E. McLaughlin, Christopher B. Cooper, Vasan K. Sambandamurthy
Publikováno v:
Journal of medicinal chemistry. 57(13)
In a previous report, we described the discovery of 1,4-azaindoles, a chemical series with excellent in vitro and in vivo antimycobacterial potency through noncovalent inhibition of decaprenylphosphoryl-β-d-ribose-2'-epimerase (DprE1). Nevertheless,
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.